Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN144,04144,160,72
Msft-0,12
Nokia13,24513,2659,73
IBM0,34
Mercedes-Benz Group AG50,1250,120,72
PFE-0,19
23.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 22.05.2026
Medifast (MDFT.F, Frankfurt)
Závěr k 22.5.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
10,24 -0,58 -0,06 512
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 25.05.2026
Popis společnosti
Obecné informace
Název společnostiMedifast Inc
TickerMED
Kmenové akcie:Ordinary Shares
RICMED
ISIN-
Prioritní akciePreference Shares Series C
Prioritní akciePreference Shares Series B
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 380
Akcie v oběhu k 27.04.2026 11 119 115
MěnaUSD
Kontaktní informace
Ulice100 International Drive, 18th Floor
MěstoBALTIMORE
PSČ21202
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon13 023 513 367
Fax14105818070

Business Summary: Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA. It sells a variety of weight loss, weight management and healthy living products all based on its proprietary formulas under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories. Its product line includes approximately 74 consumable options, including, but not limited to, bars, cereal, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. Its OPTAVIA ASCEND mini meals deliver nutrition that gives clients’ bodies what they need to - whether losing weight on a GLP-1 medication or in weight management mode. Its OPTAVIA Fuelings contain approximately 24 vitamins and minerals, high quality, complete protein, and no colors, flavors or sweeteners from artificial sources.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Medifast Inc revenues decreased 34% to $76M. Net loss increased from $772K to $2.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects OPTAVIA segment loss increase from $1.3M to $3.3M, United States segment loss increase from $1.3M to $3.3M.
Odvětvová klasifikace
TRBC2012Special Foods & Wellbeing Products
RBSS2004Pharmaceuticals - Generic & Specialty
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSDry, Condensed, and Evaporated Dairy Product Manufacturing
NAICSAll Other Miscellaneous Retailers
NAICSGeneral Medical and Surgical Hospitals
NAICSService Establishment Equipment and Supplies Merchant Wholesalers
NAICSDiet and Weight Reducing Centers
NAICSLessors of Nonfinancial Intangible Assets (except Copyrighted Works)
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICDry/condensed/evaporated Products
SICMisc Retail Stores, Nec
SICGeneral Med'L/surgical Hospitals
SICService Establishment Equipment
SICMisc Personal Services, Nec
SICPatent Owners And Lessors
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 25.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerDaniel Chard6110.12.202003.10.2016
PresidentNicholas Johnson4605.01.2026
Chief Financial OfficerJames Maloney5813.09.202120.07.2020
Chief Human Resources OfficerClaudia Greninger5301.10.2019
Chief Accounting Officer, Vice President - FinanceJonathan MacKenzie5513.09.202113.09.2021
Chief Legal Officer and Corporate SecretaryJason Groves5517.11.2011